Portal:Viruses

From Wikipedia, the free encyclopedia

The Viruses Portal
Welcome!

The capsid of SV40, an icosahedral virus
The capsid of SV40, an icosahedral virus

Viruses are small infectious agents that can replicate only inside the living cells of an organism. Viruses infect all forms of life, including animals, plants, fungi, bacteria and archaea. They are found in almost every ecosystem on Earth and are the most abundant type of biological entity, with millions of different types, although only about 6,000 viruses have been described in detail. Some viruses cause disease in humans, and others are responsible for economically important diseases of livestock and crops.

Virus particles (known as virions) consist of genetic material, which can be either DNA or RNA, wrapped in a protein coat called the capsid; some viruses also have an outer lipid envelope. The capsid can take simple helical or icosahedral forms, or more complex structures. The average virus is about 1/100 the size of the average bacterium, and most are too small to be seen directly with an optical microscope.

The origins of viruses are unclear: some may have evolved from plasmids, others from bacteria. Viruses are sometimes considered to be a life form, because they carry genetic material, reproduce and evolve through natural selection. However they lack key characteristics (such as cell structure) that are generally considered necessary to count as life. Because they possess some but not all such qualities, viruses have been described as "organisms at the edge of life".

Selected disease

Child with smallpox rash, showing the characteristic raised blisters with a central depression
Child with smallpox rash, showing the characteristic raised blisters with a central depression

Smallpox is an eradicated infectious disease of humans caused by the Variola major and V. minor viruses. V. major causes a serious disease with a mortality rate of around 30%; V. minor is associated with much milder symptoms and mortality below 1%. The virus is mainly transmitted by the respiratory route but can also be carried on contaminated objects. Smallpox preferentially infects skin cells, resulting in a usually maculopapular rash, and later, raised fluid-filled blisters. Most V. major survivors have permanent scarring, commonly on the face, which can be extensive. Less common long-term complications include blindness resulting from corneal ulceration and scarring, and in young children, limb deformities due to arthritis and osteomyelitis.

Smallpox probably emerged in human populations in about 10,000 BC; the mummified body of Egyptian pharaoh Ramses V shows evidence of smallpox rash. The disease was responsible for an estimated 300–500 million deaths during the 20th century. Smallpox vaccine, the earliest vaccine, was developed in the 18th century. After intensive vaccination campaigns, the last natural infection occurred in 1977. Smallpox was certified the first infectious disease to be eradicated globally in 1979. Debate is ongoing over whether all stocks of the virus should be destroyed.

Selected image

Scanning electron micrograph of HIV budding from lymphocytes

HIV-1 budding from lymphocytes in culture. HIV establishes a latent infection in several types of immune cell and causes profound immunodeficiency.

Credit: C. Goldsmith (1984)

In the news

Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data
Map showing the prevalence of SARS-CoV-2 cases; black: highest prevalence; dark red to pink: decreasing prevalence; grey: no recorded cases or no data

26 February: In the ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 110 million confirmed cases, including 2.5 million deaths, have been documented globally since the outbreak began in December 2019. WHO

18 February: Seven asymptomatic cases of avian influenza A subtype H5N8, the first documented H5N8 cases in humans, are reported in Astrakhan Oblast, Russia, after more than 100,0000 hens died on a poultry farm in December. WHO

14 February: Seven cases of Ebola virus disease are reported in Gouécké, south-east Guinea. WHO

7 February: A case of Ebola virus disease is detected in North Kivu Province of the Democratic Republic of the Congo. WHO

4 February: An outbreak of Rift Valley fever is ongoing in Kenya, with 32 human cases, including 11 deaths, since the outbreak started in November. WHO

21 November: The US Food and Drug Administration (FDA) gives emergency-use authorisation to casirivimab/imdevimab, a combination monoclonal antibody (mAb) therapy for non-hospitalised people twelve years and over with mild-to-moderate COVID-19, after granting emergency-use authorisation to the single mAb bamlanivimab earlier in the month. FDA 1, 2

18 November: The outbreak of Ebola virus disease in Équateur Province, Democratic Republic of the Congo, which started in June, has been declared over; a total of 130 cases were recorded, with 55 deaths. UN

Selected article

Cases of polio in 2005 (top) and 2019 (bottom). Red: endemic; orange: re-established; green: imported; blue: vaccine derived; grey: none
Cases of polio in 2005 (top) and 2019 (bottom). Red: endemic; orange: re-established; green: imported; blue: vaccine derived; grey: none

A global drive to eradicate poliovirus started in 1988, when there were an estimated 350,000 cases of wild poliovirus infection globally. Two diseases, both caused by viruses, have been eradicated, smallpox in 1980 and rinderpest in 2011. Poliovirus only infects humans. It persists in the environment for a few weeks at room temperature and a few months at 0–8 °C. The oral polio vaccine is inexpensive, highly effective and is predicted to generate lifelong immunity. Reversion of live vaccine strains to virulence has resulted in occasional cases of vaccine-associated polio paralysis.

Two of the three strains of wild-type poliovirus have been eradicated. Annual reported cases of wild poliovirus infection fell to a low of 22 in 2017, but had risen to 176 in 2019. As of 2020, the wild virus remains endemic only in Afghanistan and Pakistan, but vaccine-derived poliovirus is circulating in several countries. A lack of basic health infrastructure and civil war remain significant obstacles to eradication. Some local communities have opposed immunisation campaigns, and vaccination workers have been murdered in Pakistan and Nigeria.

Selected outbreak

The masked palm civet (Paguma larvata) is thought to have been the source of SARS coronavirus

In the severe acute respiratory syndrome (SARS) outbreak, the first cases of the newly emerged SARS coronavirus were reported in November 2002 from the Chinese Guangdong province. The virus soon spread across Asia, with China, Hong Kong, Taiwan and Singapore being the worst affected countries; a secondary outbreak occurred in Canada. The rapid initial spread of the outbreak has been in part attributed to China's slow response to the early cases. Over 8,000 people were infected, with a case fatality rate of 11%. Those over 65 years had a much higher mortality rate, greater than 55%. The outbreak was contained by July 2003, and no cases have been reported since 2004.

At the time of the outbreak, the immediate source of SARS coronavirus was thought to have been the masked palm civet (Paguma larvata; pictured), which was sold as food in Guangdong markets. The virus was also found in raccoon dogs, ferret badgers and domestic cats. More recent research has suggested that the natural reservoir could be horseshoe bats.

Selected quotation

Peter Simmonds

Recommended articles

Viruses & Subviral agents: bat virome • elephant endotheliotropic herpesvirus • HIV • introduction to viruses • Playa de Oro virus • poliovirus • prion • rotavirus • virus

Diseases: colony collapse disorder • common cold • croup • dengue fever • gastroenteritis • Guillain–Barré syndrome • hepatitis B • hepatitis C • hepatitis E • herpes simplex • HIV/AIDS • influenza • meningitis • myxomatosis • polio • pneumonia • shingles • smallpox

Epidemiology & Interventions: 2007 Bernard Matthews H5N1 outbreak • Coalition for Epidemic Preparedness Innovations • Disease X • 2009 flu pandemic • HIV/AIDS in Malawi • polio vaccine • Spanish flu • West African Ebola virus epidemic

Virus–Host interactions: antibody • host • immune system • parasitism • RNA interference

Methodology: metagenomics

Social & Media: And the Band Played On • Contagion • "Flu Season" • Frank's Cock • Race Against Time: Searching for Hope in AIDS-Ravaged Africa • social history of viruses • "Steve Burdick" • "The Time Is Now" • "What Lies Below"

People: Brownie Mary • Macfarlane Burnet • Bobbi Campbell • Aniru Conteh • people with hepatitis C • HIV-positive people • Bette Korber • Henrietta Lacks • Linda Laubenstein • Barbara McClintock • poliomyelitis survivors • Joseph Sonnabend • Eli Todd • Ryan White

Selected virus

Type 3 poliovirus capsid
Type 3 poliovirus capsid

Poliovirus is an enterovirus, an RNA virus in the Picornaviridae family, associated with the paralytic disease polio. The icosahedral virus particle is about 30 nanometres in diameter and lacks an envelope. It contains a relatively short, single-stranded positive RNA genome of around 7500 nucleotides, which encodes about ten viral products. The virus has a fairly high mutation rate even for an RNA virus. Historically there were three serotypes, each with a slightly different capsid protein; PV1 is the most common, and PV2 was declared eradicated in 2015.

The virus only naturally infects humans, although some monkeys can be infected experimentally; 95% of infections are asymptomatic. Infection occurs via the faecal–oral route and viral replication occurs in the alimentary tract. The virus enters the host cell by binding to an immunoglobulin-like receptor, CD155. Fully assembled poliovirus leaves the cell 4–6 hours after initiation of infection. Poliovirus was first isolated in 1909 by Karl Landsteiner and Erwin Popper. Its genome was sequenced in 1981. Among the simplest clinically significant viruses, poliovirus is one of the best-characterised viruses, and has become a useful model for studying RNA viruses.

Did you know?

Electron micrograph of coronaviruses
Electron micrograph of coronaviruses

Selected biography

Jonas Salk (1955)

Jonas Edward Salk (28 October 1914 – 23 June 1995) was an American medical researcher and virologist, best known for developing the first successful polio vaccine.

Unlike most other researchers, Salk focused on creating an inactivated or "killed" virus vaccine, for safety reasons. The vaccine he developed combines three strains of wild-type poliovirus, inactivated with formalin. The field trial that tested its safety and efficacy in 1954 was one of the largest carried out to date, with vaccine being administered to over 440,000 children. When the trial's success was announced, Salk was hailed as a miracle worker and national hero. A little over two years later, 100 million doses of the vaccine had been distributed throughout the US, with few reported adverse effects. An inactivated vaccine based on the Salk vaccine is the mainstay of polio control in many developed countries.

Salk also researched vaccines against influenza and HIV. In 1960, he founded the Salk Institute for Biological Studies research centre in La Jolla, California.

In this month

Painting depicting Jenner inoculating Phipps by Ernest Board (c. 1910)

May 1955: First issue of Virology; first English-language journal dedicated to virology

4 May 1984: HTLV-III, later HIV, identified as the cause of AIDS by Robert Gallo and coworkers

5 May 1939: First electron micrographs of tobacco mosaic virus taken by Helmut Ruska and coworkers

5 May 1983: Structure of influenza neuraminidase solved by Jose Varghese, Graeme Laver and Peter Colman

8 May 1980: WHO announced formally the global eradication of smallpox

11 May 1978: SV40 sequenced by Walter Fiers and coworkers

12 May 1972: Gene for bacteriophage MS2 coat protein is sequenced by Walter Fiers and coworkers, the first gene to be completely sequenced

13 May 2011: Boceprevir approved for the treatment of chronic hepatitis C virus (HCV) infection, the first direct-acting antiviral for HCV

14 May 1796: Edward Jenner inoculated James Phipps (pictured) with cowpox

15/16 May 1969: Death of Robert Rayford, the earliest confirmed case of AIDS outside Africa

18 May 1998: First World AIDS Vaccine Day

20 May 1983: Isolation of the retrovirus LAV, later HIV, by Luc Montagnier, Françoise Barré-Sinoussi and coworkers

23 May 2011: Telaprevir approved for the treatment of chronic HCV infection

25 May 2011: WHO declared rinderpest eradicated

31 May 1937: First results in humans from the 17D vaccine for yellow fever published by Max Theiler and Hugh H. Smith

Selected intervention

Ball-and-stick model of oseltamivir

Oseltamivir (also Tamiflu) is an oral antiviral drug against influenza (flu). It was the second inhibitor of the viral neuraminidase to be developed, after zanamivir, and the first to be taken as an oral tablet. It was originally synthesised from shikimic acid extracted from the star anise plant. Oseltamivir is a prodrug that requires metabolism in the liver to the active form, oseltamivir carboxylate. This binds at the active site of the neuraminidase enzyme, preventing it from cleaving sialic acid to release the virus particle from the host cell. Oseltamivir can reduce the duration of influenza symptoms by 0.5–1 days. Debate is ongoing about whether it also reduces the risk of complications, such as pneumonia. Nausea and vomiting are the main adverse events. Resistance to oseltamivir has been observed in some strains of influenza virus, especially H1N1 strains.

Subcategories

Topics

Things to do

WikiProjects & Portals

WikiProject Viruses
Related WikiProjects

MedicineMicrobiologyMolecular & Cellular BiologyVeterinary Medicine

Related Portals

Associated Wikimedia

The following Wikimedia Foundation sister projects provide more on this subject: